Radical Hysterectomy for Cervical Cancer: the Right Surgical Approach

医学 根治性子宫切除术 剖腹手术 宫颈癌 子宫切除术 腹腔镜检查 围手术期 癌症 外科 普通外科 回顾性队列研究 内科学
作者
Benny Brandt,Gabriel Levin,Mario M. Leitao
出处
期刊:Current Treatment Options in Oncology [Springer Science+Business Media]
卷期号:23 (1): 1-14 被引量:15
标识
DOI:10.1007/s11864-021-00919-z
摘要

Radical hysterectomy with pelvic lymph node assessment is the standard initial therapy for early-stage cervical cancer. Radical hysterectomy via laparotomy (an "open" approach) was first described more than 100 years ago and has been the standard for decades. Minimally invasive surgery (MIS) has been increasingly adopted by many surgeons due to its reported perioperative benefits. MIS was deemed safe for radical hysterectomy for many years based on multiple retrospective publications. Recently, the Laparoscopic Approach to Cervical Cancer (LACC) trial reported that patients randomized to MIS had inferior oncologic outcomes. The results of the LACC trial and subsequent retrospective studies led multiple professional societies to state that open radical hysterectomy should remain the gold standard surgical approach. We acknowledge that the open approach for radical hysterectomy is an appropriate option for all cervical cancer patients eligible for surgical treatment. However, considering the limitations of the LACC trial and the available data from other retrospective studies, we feel the MIS approach should not be simply abandoned. There may still be a role for MIS in cervical cancer surgery for properly and carefully selected cases and with detailed counseling; surgeons should analyze their own outcomes closely in order to perform such counseling. Modification of surgical technique and maintaining proper oncologic surgical principles are key for MIS to remain a viable option. Tumor manipulation and contamination should be avoided. Transcervical uterine manipulators should not be used. Cervical and tumor containment prior to colpotomy, as is performed during an open approach, is required. This will all require validation in future trials. We await the results of ongoing randomized trials to further inform us. A one-size-fits-all approach may be short-sighted; we may need to decide treatment strategy based on the notion of the right surgical approach for the right patient by the right surgeon.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
玉龙月发布了新的文献求助10
1秒前
4秒前
5秒前
小华乂跤417完成签到,获得积分10
5秒前
香蕉觅云应助QingMRI采纳,获得10
5秒前
wuqi完成签到,获得积分10
5秒前
Plum22发布了新的文献求助10
6秒前
沙耶酱完成签到,获得积分10
7秒前
赵文若完成签到,获得积分10
11秒前
12秒前
刘佳欣完成签到,获得积分20
12秒前
13秒前
13秒前
14秒前
18秒前
Crimson发布了新的文献求助10
18秒前
byyyy完成签到,获得积分10
19秒前
zoro完成签到,获得积分10
19秒前
路弈完成签到,获得积分10
20秒前
小二郎应助GG小丁同学采纳,获得10
21秒前
QingMRI发布了新的文献求助10
24秒前
25秒前
31秒前
37秒前
昭谏完成签到,获得积分10
38秒前
慕青应助zhul采纳,获得10
40秒前
yhhhhh发布了新的文献求助10
42秒前
不安梦桃完成签到 ,获得积分10
42秒前
桐桐应助小满胜万全采纳,获得10
45秒前
所所应助霸气的梦露采纳,获得10
47秒前
科研通AI5应助ct551144采纳,获得10
48秒前
重要忆秋完成签到,获得积分10
48秒前
49秒前
研友_VZG7GZ应助cnulee采纳,获得10
49秒前
Andrew完成签到,获得积分10
49秒前
爆米花应助昭谏采纳,获得10
50秒前
喔喔佳佳完成签到 ,获得积分10
51秒前
蓝桉完成签到,获得积分10
51秒前
恐怖稽器人完成签到,获得积分10
52秒前
HMR完成签到 ,获得积分10
53秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Fashion Brand Visual Design Strategy Based on Value Co-creation 350
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3777918
求助须知:如何正确求助?哪些是违规求助? 3323510
关于积分的说明 10214659
捐赠科研通 3038693
什么是DOI,文献DOI怎么找? 1667611
邀请新用户注册赠送积分活动 798220
科研通“疑难数据库(出版商)”最低求助积分说明 758315